The Pediatric Infectious Disease Journal. 24(10):925-927, OCTOBER 2005
DOI: 10.1097/01.inf.0000180978.66362.d9
,
PMID: 16220095
Issn Print: 0891-3668
Publication Date: October 2005
IMMUNOGENICITY AND SAFETY OF INACTIVATED INFLUENZA VIRUS VACCINE IN YOUNG CHILDREN IN 2003–2004
Douglas Mitchell;Frederick Ruben;Stefan Gravenstein;
+ Author Information
From the *Center for Pediatric Research and the †Glennan Center for Geriatrics and Gerontology, Eastern Virginia Medical School, Norfolk, VA; and ‡sanofi pasteur, Swiftwater, PA
Abstract
This study assessed the safety and immunogenicity of a pediatric formulation of the 2003–2004 inactivated, trivalent, split virion influenza vaccine, administered in a 2-dose schedule in healthy children ages 6–36 months, of whom 94% had protective titers (≥1/40) to at least 1 antigen. The 2003–2004 split virion influenza vaccine was safe and immunogenic in young children.
